Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
Year: 2011
Type: article
Abstract: Evidence-based guidelines for the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections were prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). The guidelines are intended for use by health care providers who care for adult and pediatric patients with MRSA infections. The guidelines discuss the management of a variety of clinical syndromes associated with MRSA disease, including skin and soft tissue infections (SSTI), bacteremia and endocarditis, pneumonia, bone and joint infections, and central nervous system (CNS) infections. Recommendations are provided regarding vancomycin dosing and monitoring, management of infections due to MRSA strains with reduced susceptibility to vancomycin, and vancomycin treatment failures.
Source: Clinical Infectious Diseases
DOI: 10.1093/cid/ciq146
Institutions: University of California, San Francisco, University of California, Los Angeles, Harbor–UCLA Medical Center, Johns Hopkins University, Johns Hopkins Medicine, University of Chicago, Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Baylor College of Medicine, Beth Israel Deaconess Medical Center, Harvard University, Wayne State University, Detroit Receiving Hospital, The University of Texas Health Science Center at Houston, Olive View-UCLA Medical Center, San Francisco General Hospital
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2108433768